(Q28118859)

Mitogen-activated protein kinase kinase 2

1 reference

Mitogen-activated protein kinase kinase 1

1 reference

positive regulation of production of miRNAs involved in gene silencing by miRNA

1 reference

author name string

Xiao-Bin Lv

1

1 reference

4 January 2017

Xing Zhang

2

1 reference

4 January 2017

Lan Deng

3

1 reference

4 January 2017

Ling Jiang

4

1 reference

4 January 2017

Wei Meng

5

1 reference

4 January 2017

Zhigang Lu

6

1 reference

4 January 2017

Xiuju Wang

Cell Biology International

7

1 reference

4 January 2017

1 April 2014

1 reference

4 January 2017

1 reference

4 January 2017

38

1 reference

4 January 2017

435–443

1 reference

4 January 2017

4

1 reference

4 January 2017

Transcriptional regulation of Bim by FoxO3A mediates hepatocyte lipoapoptosis

1 reference

https://api.crossref.org/works/10.1002%2FCBIN.10225

MicroRNA signatures in human cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIN.10225

Phase II trial of MEK inhibitor selumetinib (AZD6244, ARRY-142886) in patients with BRAFV600E/K-mutated melanoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIN.10225

Multikinase inhibitor sorafenib exerts cytocidal efficacy against Non-Hodgkin lymphomas associated with inhibition of MAPK14 and AKT phosphorylation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIN.10225

Phosphoproteome dynamics reveal novel ERK1/2 MAP kinase substrates with broad spectrum of functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIN.10225

(18)F-FLT-PET for Response Evaluation of MEK Inhibitor Selumetinib (AZD6244, ARRY-142886) in Patients with Solid Tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIN.10225

The Role of microRNAs in the Tumorigenesis of Ovarian Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIN.10225

The MAPK signalling pathways and colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIN.10225

Selumetinib in women with recurrent low-grade serous carcinoma of the ovary or peritoneum: an open-label, single-arm, phase 2 study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIN.10225

AP-1 function and regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIN.10225

Up-regulation of pro-apoptotic protein Bim and down-regulation of anti-apoptotic protein Mcl-1 cooperatively mediate enhanced tumor cell death induced by the combination of ERK kinase (MEK) inhibitor and microtubule inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIN.10225

In vivo activity of combined PI3K/mTOR and MEK inhibition in a Kras(G12D);Pten deletion mouse model of ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIN.10225

Targeting the ERK signaling pathway in cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIN.10225

MEK inhibition induced downregulation of MRP1 and MRP3 expression in experimental hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIN.10225

Serum miR-21 and miR-92a as biomarkers in the diagnosis and prognosis of colorectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIN.10225

MiR-138 suppressed nasopharyngeal carcinoma growth and tumorigenesis by targeting the CCND1 oncogene

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIN.10225

miR-124 suppresses multiple steps of breast cancer metastasis by targeting a cohort of pro-metastatic genes in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIN.10225

Long noncoding RNA HOTAIR is a prognostic marker for esophageal squamous cell carcinoma progression and survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIN.10225

Activity of the MEK inhibitor selumetinib (AZD6244; ARRY-142886) in nasopharyngeal cancer cell lines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIN.10225

Simultaneous inhibition of pan-phosphatidylinositol-3-kinases and MEK as a potential therapeutic strategy in peripheral T-cell lymphomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIN.10225

How ERK1/2 activation controls cell proliferation and cell death: Is subcellular localization the answer?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIN.10225

Inhibition of MEK and PI3K/mTOR suppresses tumor growth but does not cause tumor regression in patient-derived xenografts of RAS-mutant colorectal carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIN.10225

Downregulation of miR-302c and miR-520c by 1,25(OH)2D3 treatment enhances the susceptibility of tumour cells to natural killer cell-mediated cytotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIN.10225

CCL11-CCR3 interactions promote survival of anaplastic large cell lymphoma cells via ERK1/2 activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIN.10225

Regulation of the transcriptional activity of c-Fos by ERK. A novel role for the prolyl isomerase PIN1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIN.10225

MAP kinase-mediated c-fos regulation relies on a histone acetylation relay switch

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIN.10225

Selumetinib (AZD6244; ARRY-142886) in the treatment of metastatic melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIN.10225

MiR-494 is regulated by ERK1/2 and modulates TRAIL-induced apoptosis in non-small-cell lung cancer through BIM down-regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIN.10225

ERK1/2 MAP kinases: structure, function, and regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIN.10225

Targeting MEK induces myeloma-cell cytotoxicity and inhibits osteoclastogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIN.10225

miR-92 is a key oncogenic component of the miR-17-92 cluster in colon cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIN.10225

Colorectal cancer cells with the BRAF(V600E) mutation are addicted to the ERK1/2 pathway for growth factor-independent survival and repression of BIM.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIN.10225